PE-conjugated Anti-CD19 (inebilizumab biosimilar)mAb

PE-conjugated Anti-CD19 (inebilizumab biosimilar)mAb
Artikelnummer
DMABME100051P-100
Verpackungseinheit
100 test
Hersteller
DIMA Biotechnology

Verfügbarkeit: wird geladen...
Preis wird geladen...
Background: Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Description: PE-conjugated Anti-CD19 (inebilizumab biosimilar)mAb

Storage & Shipping: Store at 2°C-8°C fo 6 months

Formulation & Reconstitution: Liquid,PBS with 0.05% Proclin300, 240% BSA

Target: CD19

Uniprot ID: P15391

Usage: Research use only

Recommended Dilutions: Flow Cyt 1:100

Common Name: MEDI-551,Medi-551

Guarantee: 6 months from date of dispatch
Mehr Informationen
Artikelnummer DMABME100051P-100
Hersteller DIMA Biotechnology
Hersteller Artikelnummer BME100051P-100
Verpackungseinheit 100 test
Mengeneinheit STK
Reaktivität Human
Methode Flow Cytometry
Isotyp IgG1
Wirt Human
Konjugat Conjugated, PE (Phycoerythrin)
Produktinformation (PDF) Download
MSDS (PDF) Download